SEC Form 4 · accession 0001144204-15-000234
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M Klosk
Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 2, 2015 · 9:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Jan 2, 2015 | A | 12,000 | $0.00 | A | 22,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On January 2, 2015 (the "Grant Date"), the Reporting Person was granted an award of 19,000 shares of the Issuer's common stock, $.001 par value, subject to all of the terms and conditions of the Issuer's 2009 Amended & Restated Equity Compensation Plan. The grant was made pursuant to the Issuer's Director Compensation Plan. This award was fully vested on the Grant Date.